Mawi - Biosampling Reinvented
Mawi - Biosampling Reinvented
  • PRODUCTS
  • LIBRARY
    • Articles & Applications
    • DNA/RNA Extraction methods
    • Blog
    • FAQ
  • ABOUT US
    • Careers
    • Our Technology
  • CONTACT
Request sample kit

News

  • Active Partnerships
  • Press
  • Blog
    • About Mawi DNA Technolgies
    • Announcements
    • Articles & Cohort Studies
    • Biosampling Technology
    • Events
    • Hematology
    • In The Press
    • iSWAB Insights
    • News
    • Uncategorized
  • Blog
  • Articles & Cohort Studies
  • Exome Sequencing of Two Siblings with Sporadic Autism Spectrum Disorder and Severe Speech Sound Disorder Suggests Pleiotropic and Complex Effects
Jul 30, 2019

Exome Sequencing of Two Siblings with Sporadic Autism Spectrum Disorder and Severe Speech Sound Disorder Suggests Pleiotropic and Complex Effects

Article Abstract

Recent studies of autism spectrum disorder (ASD) and childhood apraxia of speech (CAS) have resulted in conflicting conclusions regarding the comorbidity of these disorders on phenotypic grounds. In a nuclear family with two dually affected and one unaffected offspring, whole-exome sequences were evaluated for single nucleotide and indel variants and CNVs. The affected siblings but not the unaffected sibling share a rare deleterious compound heterozygous mutation in WWOX, implicated both in ASD and motor control. In addition, one of the affected children carries a rare deleterious de novo mutation in the ASD candidate gene RIMS1. The two affected children but not their unaffected sibling inherited deleterious variants with relevance for ASD and/or CAS. WWOX, RIMS1, and several of the genes harboring the inherited variants are expressed in the brain during prenatal and early postnatal development. Results suggest compound heterozygosity as a cause of ASD and CAS, pleiotropic gene effects, and potentially additional, complex genetic effects.

 

For more information, read the study here.

Related news

Apr 17, 2023

Candida Data Using iSWAB In Response to New Infectious Diseases...

A deadly fungal infection, Candida Auris, is becoming a serious threat. This drug-resistant strain is deadly for those with weakened immune systems and is spreading at an alarming rate. The READ MORE

Apr 11, 2023

Top Reasons to Ditch Your Current VTM. Upgrade your Viral…...

Mawi DNA has developed iSWAB-RC-EL, an FDA approved sample collection device for transport and storage of samples suspected of containing an infectious disease*. Why iSWAB-RC-EL is the superior op...

READ MORE
Apr 11, 2023

Mawi DNA Announces Dr. Bouzyk as New Board Member!...

It is with great delight and excitement that we announce that Dr. READ MORE

Join our mailing list for updates and news about mawi

      • Our Product
      • FAQ
      • About Us
      • Contact
      • Resources
      • Blog

    Mawitessia

    265, Boulevard Zerktouni, No 92,
    Casablanca, Maroc

    Telephone: +212.5.22.97.51.51

    Email info@mawitessia.com

    LinkedinLinkedin TwitterTwitter

    Copyright © 2024 Mawitessia.